Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model.

Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D, Klejbor I, Bencherif M, Birkaya B, Corso T, Parikh A, Tzanakakis ES, Wersinger S, Stachowiak EK.

Schizophr Res. 2013 Feb;143(2-3):367-76. doi: 10.1016/j.schres.2012.11.004. Review.

PMID:
23231877
2.

Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

Klejbor I, Kucinski A, Wersinger SR, Corso T, Spodnik JH, Dziewiatkowski J, Moryś J, Hesse RA, Rice KC, Miletich R, Stachowiak EK, Stachowiak MK.

Schizophr Res. 2009 Sep;113(2-3):308-21. doi: 10.1016/j.schres.2009.06.006.

3.

Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.

Klejbor I, Myers JM, Hausknecht K, Corso TD, Gambino AS, Morys J, Maher PA, Hard R, Richards J, Stachowiak EK, Stachowiak MK.

J Neurochem. 2006 Jun;97(5):1243-58.

4.

Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons.

Baron O, Förthmann B, Lee YW, Terranova C, Ratzka A, Stachowiak EK, Grothe C, Claus P, Stachowiak MK.

J Biol Chem. 2012 Jun 8;287(24):19827-40. doi: 10.1074/jbc.M112.347831.

5.

The neurodevelopmental model of schizophrenia: update 2005.

Rapoport JL, Addington AM, Frangou S, Psych MR.

Mol Psychiatry. 2005 May;10(5):434-49. Review.

PMID:
15700048
6.

Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by α7 nicotinic receptor agonist.

Narla ST, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Prokop D, Bencherif M, Stachowiak MK.

Stem Cells Transl Med. 2013 Oct;2(10):776-88. doi: 10.5966/sctm.2012-0103.

7.

α7 nicotinic receptor agonist reactivates neurogenesis in adult brain.

Narla S, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Terranova C, Bencherif M, Stachowiak MK.

Biochem Pharmacol. 2013 Oct 15;86(8):1099-104. doi: 10.1016/j.bcp.2013.07.028. Review.

PMID:
23933384
8.

[Neurodevelopmental hypothesis in schizophrenia].

Gourion D, Gourevitch R, Leprovost JB, Olié H lôo JP, Krebs MO.

Encephale. 2004 Mar-Apr;30(2):109-18. Review. French.

PMID:
15107713
9.

MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function.

Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J, Willoughby D, Kenny PJ, Elsworth JD, Lawrence MS, Roth RH, Edbauer D, Kleiman RJ, Wahlestedt C.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3125-30. doi: 10.1073/pnas.1113793109.

10.

"Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module".

Stachowiak MK, Birkaya B, Aletta JM, Narla ST, Benson CA, Decker B, Stachowiak EK.

J Cell Physiol. 2015 May;230(5):989-1002. doi: 10.1002/jcp.24879. Review.

PMID:
25503065
11.

The neurodevelopmental hypothesis of schizophrenia, revisited.

Fatemi SH, Folsom TD.

Schizophr Bull. 2009 May;35(3):528-48. doi: 10.1093/schbul/sbn187. Review.

12.

Neuronal migration abnormalities and its possible implications for schizophrenia.

Muraki K, Tanigaki K.

Front Neurosci. 2015 Mar 10;9:74. doi: 10.3389/fnins.2015.00074. Review.

13.
14.

Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C.

Peng H, Myers J, Fang X, Stachowiak EK, Maher PA, Martins GG, Popescu G, Berezney R, Stachowiak MK.

J Neurochem. 2002 May;81(3):506-24.

15.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
16.

α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.

Kucinski A, Syposs C, Wersinger S, Bencherif M, Stachowiak MK, Stachowiak EK.

Schizophr Res. 2012 Apr;136(1-3):82-7. doi: 10.1016/j.schres.2012.01.005.

PMID:
22285656
17.

ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia.

Perez-Garcia CG.

Front Cell Neurosci. 2015 Dec 18;9:472. doi: 10.3389/fncel.2015.00472.

18.

Animal models of schizophrenia.

Young JW, Zhou X, Geyer MA.

Curr Top Behav Neurosci. 2010;4:391-433. Review.

PMID:
21312408
19.

Towards understanding the schizophrenia code: an expanded convergent functional genomics approach.

Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, Edenberg HJ, Kuczenski R, Geyer MA, Nurnberger JI Jr, Faraone SV, Tsuang MT, Niculescu AB.

Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):129-58.

PMID:
17266109
20.

MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N.

Neurobiol Dis. 2013 Jul;55:1-10. doi: 10.1016/j.nbd.2013.03.011.

Items per page

Supplemental Content

Support Center